Ricevi le ultime notizie sulle azioni Turn Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di TTRX

Ultime notizie per

Turn Therapeutics Inc is a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble APIs in oil-based carriers without the use of emulsifiers. This innovation reduces the quantity of required API inclusion by improving its bioavailability. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis.

November,6,,2022,,Brazil.,In,This,Photo,Illustration,The,Pepsico,

Earnings

Equities

Pre-Market Outlook

Markets

Trading Ideas

COST

LEVI

TTRX

Wall Street si prepara: i dati trimestrali e le mosse azionarie che stanno già scaldando la sessione odierna.

PepsiCo, Delta Air Lines e altre 3 azioni da tenere d&#39;occhio oggi

Turn Therapeutics Inc.

Health Care

Press Releases

Turn Therapeutics to Commence Trading Today on Nasdaq

Turn Therapeutics

Comments

Turn Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO